![]() | Vissza |
Vrdoljak E., Marschner N., Zielinski C., Gligorov J., Cortes J., Puglisi F., Aapro M., Fallowfield L., Fontana A., Inbar M., Kahán Zsuzsanna, Welt A., Lévy C., Brain E., Pivot X.:
Final results of the TANIA randomised phase III trial of bevacizumab after progression on first-line bevacizumab therapy for HER2-negative locally recurrent/metastatic breast cancer.
ANNALS OF ONCOLOGY, 27 (11).
pp. 2046-2052.
ISSN 0923-7534
(2016)